Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data validation
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Induced pluripotent stem cells production industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Process trends
2.1.4 Product & service trends
2.1.5 Application trends
2.1.6 End-use trends
Chapter 3 Induced Pluripotent Stem Cells Production Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of cancer
3.2.1.2 Significant therapeutic potential of iPSC
3.2.1.3 Increased applications in drug discovery & development
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory requirements
3.2.2.2 High production cost
3.3 Growth potential analysis
3.3.1 By process
3.3.2 By product & services
3.3.3 By application
3.3.4 By end-use
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic dashboard, 2023
Chapter 5 Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Process, 2018-2032 (USD Million)
5.1 Key trends, by process
5.2 Manual iPSC production process
5.3 Automated iPSC production process
Chapter 6 Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Product & Service, 2018-2032 (USD Million)
6.1 Key trends, by product & service
6.2 Products
6.2.1 Consumables & kits
6.2.2 Instruments/ devices
6.2.3 Automated platforms
6.3 Service
Chapter 7 Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Application, 2018-2032 (USD Million)
7.1 Key trends, by application
7.2 Drug development & discovery
7.3 Regenerative medicine
7.4 Toxicology studies
7.5 Other applications
Chapter 8 Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By End-use, 2018-2032 (USD Million)
8.1 Key trends, by end-use
8.2 Pharmaceutical & biotechnology companies
8.3 Research & academic institutes
8.4 Contract research organizations
Chapter 9 Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Lonza
10.2 Axol Biosciences Ltd.
10.3 Evotec SE
10.4 Hitachi Ltd.
10.5 Merck KGaA
10.6 REPROCELLS, Inc.
10.7 Fate Therapeutics
10.8 Thermo Fisher Scientific, Inc.
10.9 StemCellsFactory III
10.10 Applied StemCells, Inc.
10.11 Creative Biolabs
10.12 Bio-Techne Corporation
